Cargando…

Editorial: Pharmacokinetic differences of drugs and their regulatory mechanisms under dual status including normal and diseased organism

Detalles Bibliográficos
Autores principales:	Gong, Zipeng, Zhou, Jie, Ye, Ling, Ma, Guo, Xian, Yanfang, Kulkarni, Kaustubh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791254/ https://www.ncbi.nlm.nih.gov/pubmed/36578544 http://dx.doi.org/10.3389/fphar.2022.1063434

Ejemplares similares

Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters
por: Gong, Zipeng, et al.
Publicado: (2022)

Pharmacokinetics and tissue distribution of four major bioactive components of Cynanchum auriculatum extract: a UPLC–MS/MS study in normal and functional dyspepsia rats
por: Sun, Jia, et al.
Publicado: (2023)

Comparative pharmacokinetic study of the five anti-inflammatory active ingredients of Inula cappa in a normal and an LPS-induced inflammatory cell model
por: Huang, Jing, et al.
Publicado: (2022)

Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
por: Jia, Wei-Wei, et al.
Publicado: (2022)

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
por: von Kleist, Max, et al.
Publicado: (2020)

Editorial: Pharmacokinetic Evaluation and Modeling of Clinically Significant Drug Metabolites
por: Mircioiu, Constantin, et al.
Publicado: (2021)

Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
por: Zeitlinger, Markus, et al.
Publicado: (2023)

Editorial: Drug development of herbal medicines: Regulatory perspectives
por: Bilia, Anna Rita, et al.
Publicado: (2022)

Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
por: Mikov, Momir, et al.
Publicado: (2023)

A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside
por: Wang, Cheng, et al.
Publicado: (2022)

Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research
por: Khan, Abad, et al.
Publicado: (2023)

Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime
por: Thorsted, Anders, et al.
Publicado: (2020)

Elucidation of the Differences in Cinobufotalin’s Pharmacokinetics Between Normal and Diethylnitrosamine-Injured Rats: The Role of P-Glycoprotein
por: Zhang, Xiaojing, et al.
Publicado: (2019)

Editorial: Model organisms in renal pharmacology: 2022
por: Mahmoud, Ayman M., et al.
Publicado: (2023)

Editorial: Model organisms in predictive toxicology 2022
por: Nishimura, Yuhei, et al.
Publicado: (2023)

The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species
por: Basso, Jessica, et al.
Publicado: (2023)

Editorial: The use of real world data for regulatory purposes in the rare diseases setting
por: Giannuzzi, Viviana, et al.
Publicado: (2022)

Editorial: Therapeutic Drug Monitoring in Solid Organ Transplantation
por: Staatz, Christine E., et al.
Publicado: (2021)

Pharmacokinetics of Anthraquinones from Medicinal Plants
por: Wang, Dongpeng, et al.
Publicado: (2021)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
por: Nainu, Firzan, et al.
Publicado: (2023)

Mechanisms Underlying the Differences in the Pharmacokinetics of Six Active Constituents of Huangqi Liuyi Decoction between Normal and Diabetic Nephropathy Mouse Models
por: Wang, Qun, et al.
Publicado: (2022)

Editorial: Reducing the Harm of Medication–Recent Trends in Pharmacovigilance
por: Ramírez, Elena, et al.
Publicado: (2022)

Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study
por: Yu, Li, et al.
Publicado: (2018)

Editorial: Mechanisms Underlying Diabetes-Associated Damage in Target Tissues
por: Suarez-Alvarez, Beatriz, et al.
Publicado: (2022)

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor
por: Zhang, Meng, et al.
Publicado: (2023)

Phytochemical Characterization of Mentha spicata L. Under Differential Dried-Conditions and Associated Nephrotoxicity Screening of Main Compound With Organ-on-a-Chip
por: Li, Xian, et al.
Publicado: (2018)

Comparative Pharmacokinetics of Gallic Acid After Oral Administration of Gallic Acid Monohydrate in Normal and Isoproterenol-Induced Myocardial Infarcted Rats
por: Yu, Zhe, et al.
Publicado: (2018)

Comparative pharmacokinetics of four major compounds after oral administration of Mori Cortex total flavonoid extract in normal and diabetic rats
por: Xiong, Shan, et al.
Publicado: (2023)

Editorial: Targeting Human Inflammatory Skin Diseases With Natural Products: Exploring Potential Mechanisms and Regulatory Pathways
por: Goh, Bey Hing, et al.
Publicado: (2021)

Editorial: Plasticity in the Vertebrate Pituitary, Including Regulatory Mechanisms
por: Fontaine, Romain, et al.
Publicado: (2021)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Editorial: The polysaccharides from marine organisms and fungi: Biological functions and molecular mechanisms
por: Pereira, Leonel, et al.
Publicado: (2022)

Prediction for optimal dosage of pazopanib under various clinical situations using physiologically based pharmacokinetic modeling
por: Wu, Chunnuan, et al.
Publicado: (2022)

Role of Cardiac A(2A) Receptors Under Normal and Pathophysiological Conditions
por: Boknik, P., et al.
Publicado: (2021)

The Roles of Cardiovascular H(2)-Histamine Receptors Under Normal and Pathophysiological Conditions
por: Neumann, Joachim, et al.
Publicado: (2021)

Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
por: Yang, Xiaoxia, et al.
Publicado: (2015)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022)

Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)

Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A(2A) Receptors for the Treatment of Parkinson's Disease
por: Azam, Faizul, et al.
Publicado: (2012)

Postbiotics in the medical field under the perspective of the ISAPP definition: scientific, regulatory, and marketing considerations
por: Vinderola, Gabriel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pfrmobg3g5kpbjbqucjjos9ctv